Gilead Sciences, Inc. (GILD) Free Cash Flow Yield: 6.70%
Is Gilead Sciences, Inc.’s free cash flow yield high or low?
Gilead Sciences, Inc.'s free cash flow yield of 6.70% is 23% below its 5-year average of 8.69%, near the low end of its 5-year range (4.69%–14.79%).
The free cash flow yield for Gilead Sciences, Inc. (GILD) is 6.70% as of Wednesday, June 10, 2026. It is above its 12-month average by 10.26% (6.08%).
GILD Free Cash Flow Yield Chart
GILD Average Free Cash Flow Yield Chart
GILD Current vs Average Free Cash Flow Yield Chart
GILD Free Cash Flow Yield Metrics
FREE CASH FLOW YIELD
6.70%
FREE CASH FLOW YIELD AVG TTM
6.08%
FREE CASH FLOW YIELD AVG 3Y
7.45%
FREE CASH FLOW YIELD AVG 5Y
8.69%
FREE CASH FLOW YIELD AVG 10Y
10.15%
FREE CASH FLOW YIELD AVG 15Y
9.12%
FREE CASH FLOW YIELD AVG 20Y
8.14%
CURRENT VS TTM AVG
+10.26%
CURRENT VS 3Y AVG
-10.06%
CURRENT VS 5Y AVG
-22.91%
CURRENT VS 10Y AVG
-33.97%
CURRENT VS 15Y AVG
-26.50%
CURRENT VS 20Y AVG
-17.65%
GILD Competitors' Free Cash Flow Yield
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $151.21B | 6.70% | 6.08% | 7.45% | 8.69% |
| Abbott Laboratories (ABT) | $154.66B | 4.76% | 3.47% | 3.07% | 3.51% |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 1.90% | 1.28% | 0.87% | 1.09% |
| Pfizer Inc. (PFE) | $146.36B | 6.45% | 7.35% | 5.93% | 7.34% |
| Danaher Corporation (DHR) | $130.25B | 4.03% | 3.49% | 3.47% | 3.67% |
| CVS Health Corporation (CVS) | $125.16B | 5.89% | 6.53% | 9.25% | 10.66% |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 3.75% | 3.35% | 3.39% | 3.32% |
| Amgen Inc. (AMGN) | $183.75B | 4.65% | 5.90% | 5.48% | 5.88% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 10.43% | 13.31% | 12.26% | 10.96% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 3.31% | 3.05% | 3.42% | 3.85% |
Yield Comparison
FCF Yield
6.70%
Earnings Yield
6.03%
Dividend Yield
2.62%
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
- Shows free cash flow after capital expenditures relative to market cap
- Can be compared with earnings yield and dividend yield
- Can be compared with the company's historical range
- Can be compared with peers that report positive free cash flow
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
Gilead Sciences, Inc. Free Cash Flow Yield Formula & Definition
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Gilead Sciences, Inc. Free Cash Flow Yield FAQ
- What is the free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The free cash flow yield for GILD stock is 6.70%.
- Is Gilead Sciences, Inc.'s free cash flow yield high or low?
- Gilead Sciences, Inc.'s free cash flow yield of 6.70% is 23% below its 5-year average of 8.69%, near the low end of its 5-year range (4.69%–14.79%).
- What is the TTM average free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The TTM average free cash flow yield for GILD stock is 6.08%.
- What is the 3Y average free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The 3Y average free cash flow yield for GILD stock is 7.45%.
- What is the 5Y average free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The 5Y average free cash flow yield for GILD stock is 8.69%.
- What is the 10Y average free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The 10Y average free cash flow yield for GILD stock is 10.15%.
- What is the 15Y average free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The 15Y average free cash flow yield for GILD stock is 9.12%.
- What is the 20Y average free cash flow yield for Gilead Sciences, Inc. (GILD)?
- The 20Y average free cash flow yield for GILD stock is 8.14%.
Gilead Sciences, Inc. Free Cash Flow Yield History
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2026-06-10 | 6.70% |
| 2026-06-09 | 6.50% |
| 2026-06-08 | 6.37% |
| 2026-06-05 | 6.32% |
| 2026-06-04 | 6.31% |
| 2026-06-03 | 6.33% |
| 2026-06-02 | 6.39% |
| 2026-06-01 | 6.22% |
| 2026-05-29 | 6.07% |
| 2026-05-28 | 5.99% |
| 2026-05-27 | 6.10% |
| 2026-05-26 | 6.10% |
| 2026-05-22 | 6.07% |
| 2026-05-21 | 6.25% |
| 2026-05-20 | 6.24% |
| 2026-05-19 | 6.25% |
| 2026-05-18 | 6.29% |
| 2026-05-15 | 6.29% |
| 2026-05-14 | 6.18% |
| 2026-05-13 | 6.13% |
| 2026-05-12 | 6.05% |
| 2026-05-11 | 6.11% |
| 2026-05-08 | 6.21% |
| 2026-05-07 | 6.09% |
| 2026-05-06 | 5.54% |
| 2026-05-05 | 5.65% |
| 2026-05-04 | 5.69% |
| 2026-05-01 | 5.73% |
| 2026-04-30 | 5.77% |
| 2026-04-29 | 5.86% |
| 2026-04-28 | 5.84% |
| 2026-04-27 | 5.91% |
| 2026-04-24 | 5.79% |
| 2026-04-23 | 5.65% |
| 2026-04-22 | 5.68% |
| 2026-04-21 | 5.66% |
| 2026-04-20 | 5.55% |
| 2026-04-17 | 5.48% |
| 2026-04-16 | 5.45% |
| 2026-04-15 | 5.40% |
| 2026-04-14 | 5.37% |
| 2026-04-13 | 5.43% |
| 2026-04-10 | 5.43% |
| 2026-04-09 | 5.31% |
| 2026-04-08 | 5.33% |
| 2026-04-07 | 5.44% |
| 2026-04-06 | 5.39% |
| 2026-04-02 | 5.40% |
| 2026-04-01 | 5.38% |
| 2026-03-31 | 5.41% |
| 2026-03-30 | 5.53% |
| 2026-03-27 | 5.62% |
| 2026-03-26 | 5.51% |
| 2026-03-25 | 5.46% |
| 2026-03-24 | 5.46% |
| 2026-03-23 | 5.49% |
| 2026-03-20 | 5.50% |
| 2026-03-19 | 5.35% |
| 2026-03-18 | 5.34% |
| 2026-03-17 | 5.22% |
| 2026-03-16 | 5.20% |
| 2026-03-13 | 5.21% |
| 2026-03-12 | 5.20% |
| 2026-03-11 | 5.17% |
| 2026-03-10 | 5.08% |
| 2026-03-09 | 5.15% |
| 2026-03-06 | 5.24% |
| 2026-03-05 | 5.20% |
| 2026-03-04 | 5.09% |
| 2026-03-03 | 5.10% |
| 2026-03-02 | 5.03% |
| 2026-02-27 | 5.07% |
| 2026-02-26 | 5.25% |
| 2026-02-25 | 5.13% |
| 2026-02-24 | 5.11% |
| 2026-02-23 | 4.88% |
| 2026-02-20 | 4.83% |
| 2026-02-19 | 4.84% |
| 2026-02-18 | 4.78% |
| 2026-02-17 | 4.71% |
| 2026-02-13 | 4.71% |
| 2026-02-12 | 4.81% |
| 2026-02-11 | 4.69% |
| 2026-02-10 | 4.96% |
| 2026-02-09 | 4.82% |
| 2026-02-06 | 4.79% |
| 2026-02-05 | 4.89% |
| 2026-02-04 | 5.00% |
| 2026-02-03 | 5.10% |
| 2026-02-02 | 5.11% |
| 2026-01-30 | 5.15% |
| 2026-01-29 | 5.24% |
| 2026-01-28 | 5.23% |
| 2026-01-27 | 5.18% |
| 2026-01-26 | 5.30% |
| 2026-01-23 | 5.38% |
| 2026-01-22 | 5.57% |
| 2026-01-21 | 5.66% |
| 2026-01-20 | 5.89% |
| 2026-01-16 | 5.85% |
| 2026-01-15 | 6.02% |
| 2026-01-14 | 5.89% |
| 2026-01-13 | 6.00% |
| 2026-01-12 | 5.96% |
| 2026-01-09 | 6.04% |
| 2026-01-08 | 6.05% |
| 2026-01-07 | 5.88% |
| 2026-01-06 | 6.02% |
| 2026-01-05 | 6.18% |
| 2026-01-02 | 6.01% |
| 2025-12-31 | 5.95% |
| 2025-12-30 | 5.93% |
| 2025-12-29 | 5.85% |
| 2025-12-26 | 5.86% |
| 2025-12-24 | 5.81% |
| 2025-12-23 | 5.84% |
| 2025-12-22 | 5.89% |
| 2025-12-19 | 5.88% |
| 2025-12-18 | 6.01% |
| 2025-12-17 | 6.02% |
| 2025-12-16 | 6.15% |
| 2025-12-15 | 6.10% |
| 2025-12-12 | 6.07% |
| 2025-12-11 | 5.93% |
| 2025-12-10 | 6.02% |
| 2025-12-09 | 6.12% |
| 2025-12-08 | 6.03% |
| 2025-12-05 | 6.03% |
| 2025-12-04 | 5.96% |
| 2025-12-03 | 5.84% |
| 2025-12-02 | 5.90% |
| 2025-12-01 | 5.88% |
| 2025-11-28 | 5.81% |
| 2025-11-26 | 5.73% |
| 2025-11-25 | 5.75% |
| 2025-11-24 | 5.83% |
| 2025-11-21 | 5.77% |
| 2025-11-20 | 5.84% |
| 2025-11-19 | 5.70% |
| 2025-11-18 | 5.74% |
| 2025-11-17 | 5.89% |
| 2025-11-14 | 5.84% |
| 2025-11-13 | 5.83% |
| 2025-11-12 | 5.92% |
| 2025-11-11 | 5.96% |
| 2025-11-10 | 6.18% |
| 2025-11-07 | 6.15% |
| 2025-11-06 | 6.05% |
| 2025-11-05 | 6.09% |
| 2025-11-04 | 6.07% |
| 2025-11-03 | 6.12% |
| 2025-10-31 | 6.23% |
| 2025-10-30 | 6.30% |
| 2025-10-29 | 6.30% |
| 2025-10-28 | 6.33% |
| 2025-10-27 | 6.20% |
| 2025-10-24 | 6.17% |
| 2025-10-23 | 6.18% |
| 2025-10-22 | 6.15% |
| 2025-10-21 | 6.02% |
| 2025-10-20 | 6.06% |
| 2025-10-17 | 6.08% |
| 2025-10-16 | 6.33% |
| 2025-10-15 | 6.31% |
| 2025-10-14 | 6.30% |
| 2025-10-13 | 6.32% |
| 2025-10-10 | 6.37% |
| 2025-10-09 | 6.39% |
| 2025-10-08 | 6.31% |
| 2025-10-07 | 6.39% |
| 2025-10-06 | 6.57% |
| 2025-10-03 | 6.62% |
| 2025-10-02 | 6.75% |
| 2025-10-01 | 6.72% |
| 2025-09-30 | 6.72% |
| 2025-09-29 | 6.63% |
| 2025-09-26 | 6.66% |
| 2025-09-25 | 6.72% |
| 2025-09-24 | 6.57% |
| 2025-09-23 | 6.53% |
| 2025-09-22 | 6.64% |
| 2025-09-19 | 6.54% |
| 2025-09-18 | 6.57% |
| 2025-09-17 | 6.65% |
| 2025-09-16 | 6.73% |
| 2025-09-15 | 6.63% |
| 2025-09-12 | 6.52% |
| 2025-09-11 | 6.33% |
| 2025-09-10 | 6.48% |
| 2025-09-09 | 6.45% |
| 2025-09-08 | 6.44% |
| 2025-09-05 | 6.49% |
| 2025-09-04 | 6.62% |
| 2025-09-03 | 6.61% |
| 2025-09-02 | 6.62% |
| 2025-08-29 | 6.61% |
| 2025-08-28 | 6.63% |
| 2025-08-27 | 6.55% |
| 2025-08-26 | 6.51% |
| 2025-08-25 | 6.54% |
| 2025-08-22 | 6.51% |
| 2025-08-21 | 6.43% |
| 2025-08-20 | 6.29% |
| 2025-08-19 | 6.33% |
| 2025-08-18 | 6.33% |
| 2025-08-15 | 6.31% |
| 2025-08-14 | 6.27% |
| 2025-08-13 | 6.22% |
| 2025-08-12 | 6.22% |
| 2025-08-11 | 6.20% |
| 2025-08-08 | 6.25% |
| 2025-08-07 | 6.77% |
| 2025-08-06 | 7.09% |
| 2025-08-05 | 6.95% |
| 2025-08-04 | 6.83% |
| 2025-08-01 | 6.91% |
| 2025-07-31 | 6.96% |
| 2025-07-30 | 6.81% |
| 2025-07-29 | 6.84% |
| 2025-07-28 | 6.92% |
| 2025-07-25 | 6.73% |
| 2025-07-24 | 6.91% |
| 2025-07-23 | 6.89% |
| 2025-07-22 | 7.10% |
| 2025-07-21 | 7.22% |
| 2025-07-18 | 7.23% |
| 2025-07-17 | 7.19% |
| 2025-07-16 | 7.12% |
| 2025-07-15 | 7.17% |
| 2025-07-14 | 6.97% |
| 2025-07-11 | 7.13% |
| 2025-07-10 | 6.83% |
| 2025-07-09 | 6.91% |
| 2025-07-08 | 7.04% |
| 2025-07-07 | 6.99% |
| 2025-07-03 | 7.00% |
| 2025-07-02 | 7.01% |
| 2025-07-01 | 7.00% |
| 2025-06-30 | 7.05% |
| 2025-06-27 | 7.07% |
| 2025-06-26 | 7.27% |
| 2025-06-25 | 7.38% |
| 2025-06-24 | 7.29% |
| 2025-06-23 | 7.36% |
| 2025-06-20 | 7.20% |
| 2025-06-18 | 7.24% |
| 2025-06-17 | 7.24% |
| 2025-06-16 | 7.06% |
| 2025-06-13 | 7.11% |
| 2025-06-12 | 6.98% |
| 2025-06-11 | 7.15% |
| 2025-06-10 | 7.10% |
| 2025-06-09 | 6.92% |
| 2025-06-06 | 6.95% |
| 2025-06-05 | 7.08% |
| 2025-06-04 | 7.17% |
| 2025-06-03 | 7.15% |
| 2025-06-02 | 7.18% |
| 2025-05-30 | 7.10% |
| 2025-05-29 | 7.04% |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Daniel O'Day